KaloBios Exodus Continues With Two More Board Member DeparturesBy
Former CEO Shkreli has denied wrongdoing in fraud case
Fernandez, Biestek depart, leaving board with two directors
Two more KaloBios Pharmaceuticals Inc. board members resigned, continuing the exodus from the company previously run by Martin Shkreli after his arrest on securities fraud charges related to another drugmaker.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.